Get full access to one story every week, and to summaries of all other stories. Just create a free account

Mahendra Narwaria often conducts at least one weight loss surgery every day. As director of Ahmedabad-based Asian Bariatrics, which he claims is Asia’s largest weight loss and diabetes surgery speciality centre, he has operated on patients whose body mass index (BMI)—a measure of body-fat based on height and weight—and the diseases they suffer from classify them as obese. Patients both young and old walk through his doors, their weight anywhere between 60 to 1oo kilograms. Hundreds each year. But Narwaria believes many more Indians need access to bariatric surgery.

In India, Narwaria is a pioneer of sorts when it comes to bariatric surgery—a procedure that reduces the size of the stomach, curbing appetite to help patients shed excess weight and manage conditions such as hypertension, diabetes and fatty liver disease. When Narwaria isn’t operating on people, he trains other surgeons to conduct these surgeries. Just last week, he held classes at a 3-day-long conference to assess and upgrade the bariatric surgery skills of 70 surgeons. No small feat, give that there are only about 500 trained bariatric surgeons in the entire country as most medical colleges don’t train surgeons in these new branches of surgery.

Narwaria, though, has had help in his attempts to popularise bariatric surgery. “Johnson & Johnson supported my training and all our conferences,” he says. Without them, training surgeons for bariatric surgery would not have been possible, he adds.

Indeed, medical device companies often train and certify surgeons to get them to use the the companies’ products. And medical device major Johnson & Johnson (J&J)—which earned $76.5 billion in revenue last year—is no different. A surge in bariatric surgeries means a surge in sales of the company’s surgical staplers which are used in the procedure. Along with fellow medical device manufacturer Medtronic, J&J dominates the surgical stapler market in India.

To this end, J&J has trained surgeons in bariatric surgery, and then these surgeons have trained junior surgeons under a proctorship programme as well. This is how the pool of bariatric surgeons has swelled to around 500 now, accounting for close to 20,000 surgeries annually, explains Manish Jain, J&J’s former director of health policy.

Training surgeons, though, is just one part of the puzzle the company is trying to solve. In the case of bariatric surgery, J&J has decided to walk the extra mile and promote the procedure in India, says Jain. Since they brought the staplers to India in the early 2000s, they have jumped through one hoop after another to develop, lead and grow the fastest-growing market for bariatric surgeries—Asia. Still only a small part of the $1.64 billion global bariatric surgery device market which is growing at 5.7% annually, Asia is growing faster than Western countries. And if the Asian market is to continue this trend of rapid growth, India will prove to be a key market.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 6 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.